AI Summary & Key Takeaways
AI InsightMethods: Between April 1992 to April 1995, 610 pregnant women undergoing second trimester triple marker screening for Down's syndrome who were delivered at our institution were included to the study. 81 women with an hCG level greater than 2.0 multiples of median (MOM) served as the study group and 481 women with hCG levels
📌 3 Key Takeaways
Abstract
Objective: Our purpose was to determine whether unexplained elevations in maternal serum human chorionic gonadotropin (hCG)in the second trimester is associated with an increased risk of preeclampsia. Methods: Between April 1992 to April 1995, 610 pregnant women undergoing second trimester triple marker screening for Down's syndrome who were delivered at our institution were included to the study. 81 women with an hCG level greater than 2.0 multiples of median (MOM) served as the study group and 481 women with hCG levels
Özet
Objective: Our purpose was to determine whether unexplained elevations in maternal serum human chorionic gonadotropin (hCG)in the second trimester is associated with an increased risk of preeclampsia. Methods: Between April 1992 to April 1995, 610 pregnant women undergoing second trimester triple marker screening for Down's syndrome who were delivered at our institution were included to the study. 81 women with an hCG level greater than 2.0 multiples of median (MOM) served as the study group and 481 women with hCG levels